wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33912075-06C4F49D-9B1A-4AA6-B903-BA22DF502D01
Q33912075-06C4F49D-9B1A-4AA6-B903-BA22DF502D01
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33912075-06C4F49D-9B1A-4AA6-B903-BA22DF502D01
Molecular mechanism of PD-1/PD-L1 blockade via anti-PD-L1 antibodies atezolizumab and durvalumab.
P2860
Q33912075-06C4F49D-9B1A-4AA6-B903-BA22DF502D01
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33912075-06C4F49D-9B1A-4AA6-B903-BA22DF502D01
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
87357e5e7c56986abe801de97e26efe5ef4b11cf
P2860
Breakthrough of the year 2013. Cancer immunotherapy.